Status:

COMPLETED

Stellate Ganglion Block for Major Depressive Disorder.

Lead Sponsor:

Unity Health Toronto

Conditions:

Treatment Resistant Depression

Major Depressive Disorder

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

This is a feasibility study, to investigate a new treatment option for major depressive disorders by performing a Stellate Ganglion Block (SGB). A SGB is an injection of local anesthetic into the symp...

Eligibility Criteria

Inclusion

  • 18 - 65 years of age
  • Major depressive disorder without psychotic symptoms according to DSM-5 criteria
  • Hamilton Depression Rating Scale (HAMD)\>17
  • Current major depressive episode as confirmed by the Mini International Neuropsychiatric Interview (MINI)
  • Failure of at least two trials of antidepressant therapy during the current episode
  • Capacity to provide informed consent

Exclusion

  • Depression secondary to stroke, cancer or other severe medical illness
  • Major Depressive Episode in people with Bipolar Disorder.
  • Dementia
  • Post-Traumatic Stress Disorder (PTSD)
  • Acute suicidality defined as score ≥3 on HAMD item 3
  • Previous electroconvulsive therapy
  • Known history of intolerance of hypersensitivity to local anesthetic
  • Current substance abuse or dependence (except for caffeine or nicotine dependence) and/or recent history (last 12 months) of current alcohol abuse or dependence, as defined in DSM-5 criteria
  • Unwilling to maintain current antidepressant regimen.
  • A clinical finding/condition that is unstable or that, in the opinion of the investigator(s) would negatively be affected by an SGB (e.g. movement disorder where patient is unable to lie still for injection or anatomical variants making an SGB impractical).

Key Trial Info

Start Date :

September 23 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 10 2022

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04727229

Start Date

September 23 2021

End Date

March 10 2022

Last Update

February 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Michael's Hospital

Toronto, Ontario, Canada, M5B 1W8